Abstract 970: Broad therapy resistance is induced by suppression of apoptotic priming by lineage programs and oncogenic activation
Kristopher A. Sarosiek(Harvard University), Anthony Letai(Dana-Farber Cancer Institute), Kris C. Wood(Duke University), Andrei Goga(University of California, San Francisco), Ronny Drapkin(University of Pennsylvania), Peter Winter(Duke University), Antonio Sorrentino(Roche (Switzerland)), Alison M. Karst(Gilead Sciences (United States)), Sourav Bandyopadhyay(University of California, San Francisco)
Cited by 0
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement
|Nature Biotechnology|2013|1.3k